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U.S. EPA’s Office of
Pollution Preven-
tion and Toxics
(OPPT) has devel-
oped computerized
methods for predict-
ing the risk of indus-
trial chemical toxic-
ity based on an
analysis of chemical structure. Under the Sustain-
able Futures Pilot Project, industry is beginning
to realize tangible business and pollution preven-
tion benefits from the use of these methods.
This article discusses the development of the
Sustainable Futures program and highlights
some of the benefits to business, regulators, and
the environment. 
Background: Regulation of Chemicals
Three general groups of chemicals are regu-
lated in the United States: pesticides, pharmaceu-
ticals (drugs), and industrial chemicals. The in-
herent nature of these chemicals varies, as do the
purposes for which they are developed and used.
This has resulted in different approaches to the
regulation of these chemicals.
Pesticides and
Pharmaceuticals
Pesticides are
designed to be toxic
to specific target or-
ganisms in order to
control or eliminate
organisms that cre-
ate problems for so-
ciety (such as rats, roaches, termites, weedy plants,
molds, and other destructive microorganisms).
Pharmaceuticals are also designed to have
specific biological activities; they are used to con-
trol or eliminate infectious agents and regulate
physiological functions. 
Because pesticides and pharmaceuticals must
possess specific biological activity in order to
function in the desired manner, regulators must
be certain that their use will not result in any un-
desirable or unintended harm. In order to ensure
public safety, the U.S. Congress passed the Federal
Insecticide, Fungicide and Rodenticide Act of
1972 (FIFRA) to control pesticides. An earlier
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Congress had already adopted the Food, Drug
and Cosmetic Act of 1938 (FDCA) to control
pharmaceuticals.
These laws give regulators of these groups of
chemicals broad and specific authorities. Both
FIFRA and FDCA state that before a chemical can
enter commerce, regulators must receive specific
experimental laboratory data that clearly
demonstrate that the chemical will behave in
the prescribed manner
and not cause unin-
tended harm to hu-
mans or the environ-
ment. A wide range of
specific tests, costing
many millions of dol-
lars and multiple
years to complete, are
often required.
EPA’s Office of Pesticide Programs regulates
and controls pesticides, while the U.S. Food and
Drug Administration (FDA) regulates and con-
trols pharmaceuticals.
Industrial Chemicals
Chemicals that are not pharmaceuticals or
pesticides generally are considered “industrial
chemicals” (except for explosives and radiological
materials). Industrial chemicals serve an incredi-
bly broad range of uses.
Unlike pesticides and pharmaceuticals, in-
dustrial chemicals are not designed to have spe-
cific biological activity. As a result, no targeted
testing is required before industrial chemicals go
into commerce.
Pesticides and Pharmaceuticals Are Data-
Rich; Industrial Chemicals Are Data-Poor
Because of these different regulatory schemes,
we have different levels of knowledge about the
three groups of regulated chemicals. In general,
pesticides and pharmaceuticals are rich in pub-
licly available data, while industrial chemicals are
data-poor.
Industrial Chemicals Can Be Found Nearly
Everywhere
We all come into contact with industrial
chemicals every day. Industrial chemicals are
used in a very broad array of goods, products, and
services, including (among many others):
• laundry detergents and household cleaners;
• fabrics and carpets;
• paper finishes and inks;
• paints and dyes;
• food containers;
• personal care products, like hair- and tooth-
brushes;
• children’s toys;
• automobile components; and
• computer components.
The fresh scent of your fabric softener, the blue
dye in your jeans, that “new car smell”—all are
the result of industrial chemicals.
In addition, many solid materials, such as
particleboard in your furniture or your home,
have been produced with industrial chemicals
and may still have these chemicals as critical
components. 
The Public Becomes Aware of Industrial
Chemicals
Until the mid-1970s, there were no federal
laws controlling industrial chemicals. Regulation
of these chemicals became a priority in the
United States after the report of some major,
manmade environmental disasters.
One such incident was in the neighborhood
of Love Canal in New York State, where a school
and many homes were built on top of an old in-
dustrial dumpsite containing toxic chemicals, in-
cluding polychlorinated biphenyls (PCBs). An-
Unlike pesticides and
pharmaceuticals, industrial
chemicals are not designed to have
specific biological activity. 
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and chronic toxicity to fish, birds, and other ter-
restrial species.
These testing requirements mean that a com-
pany must invest millions of dollars in a chemi-
cal they wish to bring to market. In addition, EPA
and FDA typically take years to evaluate test data
submitted with a chemical.
The burden of proof for safety rests squarely
with the company wishing to manufacture or
import pesticides or pharmaceuticals. The com-
pany must demonstrate to the regulator that the
chemical is safe for the intended purpose. In ad-
dition, the chemical must carry an approved
label that clearly states the specifics of use (in-
cluding dose or appli-
cation rates) and pro-
hibitions on use.
The burden of proof
for safety is very differ-
ent for industrial chem-
icals. Under TSCA,
there is no require-
ment for chemical
companies to conduct testing of any kind before
commencing manufacture for commercial pur-
poses. The regulatory structure for industrial
chemicals under TSCA differs markedly from that
of drugs and pesticides. 
“Existing” versus “New” Chemicals:
Chemicals Are New by Virtue of the Law, Not
Science
Shortly after TSCA was passed in 1976, EPA is-
sued a Federal Register notice asking manufactur-
ers and importers of industrial chemicals to send
notice to the Agency (a postcard was adequate)
listing the names of chemicals they manufac-
tured or imported that were currently in com-
merce in the United States.
This list of chemicals became the TSCA In-
ventory of Existing Commercial Chemical Sub-
stances. In effect, the TSCA Inventory “grandfa-
other incident involved the discovery of exten-
sive dioxin contamination of the roads and soils
in Times Beach, Missouri.
Because of widely reported incidents such as
these, the general public began to recognize
that exposure to some industrial chemicals
could result in risks to human health and the
environment. 
Toxic Substances Control Act: Regulation of
Industrial Chemicals 
In response to these increasing concerns,
Congress passed the Toxic Substances Control Act
(TSCA) in 1976. This law authorized EPA to con-
trol the manufacture, import, use, distribution,
and disposal of industrial chemicals. TSCA is im-
plemented by EPA’s Office of Pollution Preven-
tion and Toxics.
TSCA does not require testing of new chemi-
cals, but does require that OPPT review new
chemical submissions within 90 days. 
TSCA Requirements Differ from Those of
FDCA and FIFRA
TSCA is fundamentally different from FIFRA
and FDCA because, as previously discussed, the
nature of the chemicals regulated by each law is
fundamentally different.
Pharmaceuticals and pesticides must be regis-
tered with the regulating authority before they
can enter commerce. The registration processes
require that results from specific rigorous human
health toxicity tests be submitted so that the au-
thorities can comprehensively evaluate any po-
tential risks from exposure to the chemical.
Testing may be conducted for carcinogenicity,
reproductive and developmental toxicity, chronic
toxicity, neurotoxicity, mutagenicity, organ toxic-
ity, eye irritation, and skin and/or lung sensitiza-
tion, among other endpoints. Environmental
testing is also required. This can include testing
on environmental fate and persistence, and acute
Pharmaceuticals and pesticides
must be registered with the
regulating authority before they can
enter commerce. 
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thered” chemicals that were already in commerce
at the time the Inventory was created. This grand-
fathering ended when the original TSCA Inven-
tory was completed in 1979. The original Inven-
tory contained approximately 60,000 chemicals.
This grandfathering of chemicals in com-
merce when TSCA was enacted would turn out to
be a major factor contributing to our lack of tox-
icity and risk data on chemicals in commerce, be-
cause existing chemicals are treated differently
from new chemicals under TSCA. 
EPA Must “Show Cause” to Request Data on
Existing Chemicals 
Under TSCA, man-
ufacturers and im-
porters are free to use
“existing” chemicals
(that is, those included
in the Inventory) for
any purpose. No regis-
tration or labeling is
needed.
Testing of these ex-
isting chemicals is not a condition of manufacture
or use. Under TSCA, EPA can require testing of ex-
isting chemicals if the Agency can “show cause”
why testing is necessary, and go through a lengthy
notice-and-comment rulemaking process. The
burden of proof regarding the need for testing is
on EPA and not on the manufacturers/importers/
users of these existing chemicals. 
New Chemical Submissions Often Have No
Data
TSCA requires that anyone wishing to com-
mercialize a chemical not already on the Inven-
tory (i.e., a “new” chemical) must submit a Pre-
manufacture Notice (PMN) to EPA OPPT.
As stated on the OPPT New Chemicals Pro-
gram Web site, http://www.epa.gov/oppt/new-
chems (as accessed February 19, 2004), PMN sub-
missions must include “all available data on
chemical identity, production volume, byprod-
ucts, use, environmental release, disposal prac-
tices, and human exposure.” In addition, the
PMN should include “all existing health and en-
vironmental data in the possession of the sub-
mitter, parent company, or affiliates, and a de-
scription of any existing data known to or
reasonably ascertainable by the submitter.”
The reality, however, is that most often
human health and environmental toxicity data
are not readily available to the submitter, and are
not submitted with the PMN. Submitters are not
required to do any additional specific toxicity
testing on chemical substances.
OPPT has noticed that typically only a small
fraction of PMNs contain human health or
aquatic toxicity data, and endpoints vary. OPPT
staff scientists say that about 15 percent have at
least some mammalian toxicity data, and only 4
percent have repeat dose study data (28- or 90-
day); less than 5 percent contain aquatic toxicity
data, and about 10 percent have data on physical
chemical properties and/or environmental fate (J.
V. Nabholz, R. Jones—EPA OPPT, April 15, 2004,
personal communication). In addition, the data
submitted quite often are claimed as confidential
and cannot be made publicly available.
The result is that most PMNs, even those that
do contain data, do not contain test data ade-
quate to fully characterize the risks that their
chemicals may pose. 
EPA Must Review PMNs, Which Often Lack
Data, in 90 Days 
EPA OPPT must complete their assessment of
PMNs and describe any necessary regulatory ac-
tions required to control risk within 90 days, al-
though the 90-day clock can be stopped if neces-
sary. OPPT typically regulates or controls about 10
percent of PMNs submitted. One type of regulatory
action is “prescribed use and exposure” controls. 
Under TSCA, manufacturers and im-
porters are free to use “existing”
chemicals (that is, those included
in the Inventory) for any purpose. 
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OPPT has databases of information on chemical
PMNs over the past 20-plus years, as well as the
outcome of every chemical review. 
While nearest analogue analysis is effective, it
is also time-consuming and labor-intensive. As
the volume of PMN submissions increased, the
Agency had to develop additional methods for
evaluating PMN chemicals in order to remain
within the 90-day time frame allowed by TSCA. 
Chemical Categories Approach
By the late 1980s, OPPT had enough experi-
ence with certain types
of chemicals to be able
to group them into
prescribed categories
that share common
characteristics. With
this accumulated expe-
rience, OPPT created
the Chemical Cate-
gories Report, available
online at http://www.epa.gov/oppt/newchems/
chemcat.htm. This report has information on
more than 50 classes of chemicals.
Within a prescribed category, the toxicity
concerns and test recommendations vary little
from chemical to chemical. Thus, if a new PMN
chemical is identified as being a member of an es-
tablished category, the potential health or envi-
ronmental concerns (or absence of concerns) as-
sociated with that category can be attributed to
the chemical.
While this category approach does not in-
clude all types of substances, new categories are
added when justified by data and professional
judgment. In addition, this category-based ap-
proach has allowed OPPT to share some of its ac-
cumulated expertise with the chemical industry
and the general public, even though the underly-
ing data that OPPT used to develop the categories
may be confidential. 
In the early years of TSCA, few PMNs were
submitted to EPA. The number of PMN submis-
sions has steadily increased, however, and EPA
currently receives 1,500 to 2,000 per year. In
order to deal with the increasing volume, OPPT
had to develop a process to essentially “triage”
PMNs. Chemicals known to be low-toxicity—
and, therefore, low-risk—could be given less
scrutiny, allowing EPA scientists to focus on those
chemicals that may present higher risk.
OPPT developed exemption rules for those
chemicals that the Agency believes will not pose a
risk. Examples of current exemptions are those for:
• certain polymers;
• low-volume and low-exposure chemicals; and
• research and development applications. 
OPPT’s Approach to Evaluating Chemicals in
the Absence of Data: Necessity Is the Mother
of Invention
Faced with the challenge of rapidly assessing
many chemicals that most often have no toxicity
data, the Agency developed a stepwise evaluation
process. The steps in this process include nearest
analogue analysis; the chemical categories ap-
proach; and computerized predictive methods
known as SARs and QSARs. Each of these is de-
scribed below. 
Nearest Analogue Analysis
Since no data are available for most PMN
chemicals, OPPT uses measured data on struc-
turally related compounds (analogues) to esti-
mate the toxicity of the PMN chemical.
Identification of close analogues requires the
judgment of a highly qualified chemist. OPPT is
fortunate to have experienced, exceptionally well-
qualified chemists on staff who spend most of their
time on work related to PMN chemical review.
OPPT staff search previous PMN cases to de-
termine if they have seen this chemical before.
Within a prescribed category, the
toxicity concerns and test
recommendations vary little from
chemical to chemical. 
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SARs and QSARs: Scientifically Sound
Computational Toxicology Methods
The old adage, “If it walks like a duck, and
quacks like a duck, it must be a duck” describes
the basis for Structure Activity Relationships
(SARs) and Quantitative Structure Activity Rela-
tionships (QSARs).
Rather than using a tested analogue to predict
the potential toxicity of an untested chemical,
SAR and QSAR analyses are based on observations
that the properties or toxic activities of a chemi-
cal can be associated with a particular descriptor
of the compound, such as molecular shape or
water solubility.
Using validated
measured data, a re-
gression equation can
sometimes be devel-
oped that mathemati-
cally describes the rela-
tionship between the
chemical descriptor
and the property or ac-
tivity. That regression
equation can then be used to predict the proper-
ties or toxicity of an untested chemical.
OPPT has developed a wide range of
SARs/QSARs for many endpoints, including
both human health and environmental toxicity.
One of the more widely known OPPT SAR mod-
els is ECOSAR (Ecological Structure Activity Re-
lationship), which currently contains the com-
puterized SARs equations for more than 60
chemical classes, as described in the model’s
“Help” functions.
Additional SARs are being programmed into
ECOSAR as resources allow. OPPT is also explor-
ing the development of human health QSARs
that can incorporate the wealth of data received
by the New Chemicals Program.
Development of computerized models con-
structed using confidential data received by the
Agency is another way of providing access to
EPA’s expertise, as well as permitting indirect use
of confidential data, while still ensuring the pro-
tection of companies’ proprietary interests.
In the long run, these computerized models
can make the best use of everyone’s dwindling re-
sources. They can also help avoid unnecessary
(and increasingly unpopular) animal testing.
Outreach Programs Teaching Industry To Use
EPA’s Screening Models: Legacy of the
Pollution Prevention Act 
The Pollution Prevention Act (PPA) of 1990
describes basic concepts that, if followed, will
greatly reduce environmental pollution. The PPA
creates a hierarchy of approaches for dealing with
pollution. The Act provides that pollution should
be prevented or reduced at the source if possible.
If this cannot be achieved, waste should be recy-
cled. Disposal or environmental release should
occur only as a last resort. Following passage of
the Act, EPA looked for ways to incorporate these
concepts into Agency programs.
OPPT staff, working within the New Chemi-
cals Program, were aware of a situation com-
monly encountered when PMN chemicals had to
be regulated. Staff observed that PMN submitters
often could have been alerted to potential toxic-
ity and risk concerns if, during development of
the regulated chemical, the submitter had used
the screening methods that OPPT developed to
screen PMN chemicals.
If a company that is developing a PMN sub-
mission realizes that manufacture of its chemical
would result in, for instance, worker inhalation
concerns, the submitter could request certain
worker handling practices in order to eliminate
exposure—and, therefore, risk to workers.
Similarly, if the submitter has five alternative
chemicals which, based on availability and per-
formance, could be used for the desired applica-
tion, he or she can screen all five candidates and
OPPT has developed a wide range
of SARs/QSARs for many endpoints,
including both human health and
environmental toxicity. 
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Making EPA Screening Models Available to
Industry Can Benefit Everyone Involved
Giving OPPT risk-screening methods to the
chemical industry for use at the research and de-
velopment stage seemed like an idea that could
be beneficial to everyone. These tools can help in-
dustry identify and take advantage of pollution
prevention opportunities even before a chemical
is synthesized. For this reason, OPPT wanted to
make these methods publicly available to encour-
age risk screening as early as possible in the
chemical development process.
Exhibit 1 illustrates why early prescreening
can be so beneficial to industry. As this graphic
shows, companies often do not perform toxicity
then select for the PMN the one that has the most
environmentally preferable properties (for exam-
ple, the chemical that is least toxic to fish).
In these general examples, the PMN submit-
ters would be able to avoid delays resulting from
having the Agency identify toxicity, get back to
the submitter, and require the submitter to add
the controls required to mitigate risk. 
The Agency had essentially been telling in-
dustry, “Send in your chemical and we will tell
you if it will be allowed.” By the time that OPPT
reviews a PMN, most of the pollution prevention
opportunities have already been lost. This situa-
tion does not encourage the innovation needed
to work toward preventing pollution. 
Exhibit 1. Chemical R&D Process—Status Quo
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screening until the point at which the PMN is
submitted to EPA. If the company discovers at
this stage that its chemical poses toxicity con-
cerns, it will already have spent considerable time
and resources on the development process—and
may have missed opportunities to consider alter-
natives or mitigate the toxicity threat. 
Initial reactions to EPA’s outreach efforts were
predictable. Within the Agency, some expressed
the belief that it was wrong to give industry
OPPT methods. After all, we would be using
those same methods to review industry chemi-
cals. To some, this was seen as giving the fox the
key to the henhouse!
In addition, some
method developers
were at first reluctant
to hand out their mod-
els because the models
were not well docu-
mented and had no
users’ guide. Others
wanted to enhance
their model by adding additional data.
EPA finally determined that, although the
models may not have been perfect, they could be
tremendously useful to chemical manufacturers,
formulators, and users by providing screening-
level toxicity and risk information that was not
otherwise readily available. 
Giving chemical developers additional meth-
ods to predict toxicity and risk very early in re-
search and development could maximize pollu-
tion prevention opportunities, and would lead to
the development of safer chemicals. This is pol-
lution prevention (often called P2) in its most
basic form. 
Industry’s initial reaction to this new cooper-
ative effort was understandable: Here comes the
regulator with his hand out, saying “Show me
your chemicals and I can help you!” Industry
was cautious. 
Can the Technology Be Successfully
Transferred?
OPPT wanted to conduct a small pilot project
to learn whether the risk-screening methods used
during the review of new chemicals could be suc-
cessfully transferred to the chemical industry.
Kodak Pilot Project
EPA and Eastman Kodak reached an agree-
ment to form a partnership for a pilot project.
After giving Kodak the screening models, OPPT
met with Kodak technical staff several times to
help them understand the model limitations,
practice using the models, and interpret the
model results. 
Kodak and OPPT collaborated on a series of
test cases running the models. Kodak gave OPPT
a set of chemicals, and then both Kodak and
OPPT evaluated the chemicals independently
using OPPT screening models.
When Kodak and OPPT met to compare
screening results, everyone was gratified to see
that the model results from the separate evalu-
ations were almost identical. Kodak continues
to use these screening methods after incorpo-
rating them into their chemical product devel-
opment process.
The P2 Framework Is Born
Based on the highly successful Kodak pilot
project, OPPT combined their chemical toxicity
and risk screening models into the Pollution Pre-
vention (P2) Framework. OPPT then developed
an aggressive outreach program offering seminars
and workshops on the use, interpretation, and
limitations of the P2 Framework models.
I was fortunate to be offered the task of devel-
oping the documentation for this outreach effort.
Working with EPA subject matter experts, I put
together the P2 Framework Manual, which is now
available for downloading on the P2 Framework
Web site at http://www.epa.gov/oppt/p2frame-
Within the Agency, some expressed
the belief that it was wrong to give
industry OPPT methods. 
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The cost accounting study was conducted by
the Tellus Institute, who worked with Kodak to
compare and document new chemical product
development at Kodak both before and after in-
corporating the P2 Framework models.
The Tellus Institute Kodak case study1 docu-
mented how the P2 Framework screening models
gave Kodak a competitive advantage and helped
them increase profits. The case study held a pow-
erful message that all business managers would
readily understand: Prescreening chemicals for
toxicity and risk potential at the research and de-
velopment stage improves the bottom line.
PPG Industries Validates Aquatic Toxicity
SARs in the P2 Framework
PPG Industries, a major manufacturer of
paints, coatings, glass, and fine chemicals, also
submitted a Project XL proposal based on use of
the P2 Framework. Like Kodak, PPG planned to
incorporate the P2
Framework into their
product development
efforts and share their
experience using the
Framework. In addi-
tion, PPG conducted
an independent vali-
dation of ECOSAR.
PPG had previously submitted several dozen
chemicals to both OPPT and Environment
Canada, which requires the submission of test
data with new chemical notifications. PPG com-
pared the aquatic toxicity test data submitted to
Canada against the ECOSAR predictions for
these chemicals. They concluded that ECOSAR
SARs were 87 to 90 percent accurate when com-
pared to test data.2
Regulatory Relief Was a Secondary Benefit
Kodak and PPG were eligible for regulatory re-
lief under Project XL. Both companies asked that
work. The manual describes each of the models,
explains how they are used to estimate toxicity
and risk, and includes several case studies show-
ing how the model results are used to predict po-
tential risk. 
Project XL Initiatives from Two P2
Framework Partners
Not long after OPPT released the P2 Frame-
work, EPA launched Project XL, an initiative
aimed at improving approaches to pollution pre-
vention. Project XL (standing for eXcellence and
Leadership) was open to anyone—including
chemical companies, utilities, and manufacturing
facilities—in all business sectors. Information on
Project XL is available at http://www.epa.gov/
projectxl/.
Project XL invited stakeholders to suggest in-
novative new ways to prevent or reduce pollu-
tion. Companies interested in participating sub-
mitted proposals to EPA describing their ideas. If
the proposal was accepted, the participant could
qualify for regulatory relief.
Two companies who were partnering with
OPPT to learn how to use the P2 Framework mod-
els, Eastman Kodak and PPG Industries, submit-
ted Project XL proposals based on using the mod-
els to screen chemicals at the research and
development stage.
Kodak Documents Economic and Business
Benefits from Using the P2 Framework
As documented in Kodak’s Project XL pro-
posal, the company incorporated the P2 Frame-
work into their research and development
process. Kodak shared their experience using the
P2 Framework with others in the industry
through publications and presentations at con-
ferences and meetings. They also conducted a
cost accounting study to describe the economic
and business benefits of applying risk screening
in research and development.
Project XL invited stakeholders to
suggest innovative new ways to
prevent or reduce pollution. 
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the usual 90-day review period be shortened to 45
days for submissions developed using the P2
Framework models under their Project XL pro-
posals. EPA agreed, and allowed Kodak and PPG
to submit a Project XL chemical as both a PMN
and a TME (Test Market Exemption), something
not ordinarily allowed under TSCA.
The benefit of the simultaneous submissions
was that when the prescreened low-toxicity/low-
risk chemical was dropped from review at day 45,
the company could begin manufacture immedi-
ately, as was customary for a TME, instead of hav-
ing to wait until the conclusion of the usual 90-
day PMN period.
Both XL projects
ran for three years. It
was very interesting to
note that PPG took ad-
vantage of the expe-
dited review only
rarely, and Kodak
never used the regula-
tory relief. Kodak
stated that the option
for regulatory relief was appealing. However, the
most significant benefits they gained came from
reduced product development costs, decreased
waste generation, reduced regulatory liability,
and the capacity to deliver products to the cus-
tomer on schedule.
The PBT Profiler: The P2 Framework’s Next
Generation
In the process of working with industry and
helping them learn to use the P2 Framework
models, OPPT learned that many companies (es-
pecially small companies) cannot afford to hire
chemists/toxicologists and get them trained in
the proper use of screening models.
Partly in response to this, OPPT developed the
PBT Profiler from components of the P2 Frame-
work. The Profiler represents an effort to develop
a model that will be widely available to industry,
easy to use and interpret, and helpful in identify-
ing potentially persistent, bioaccumulative, and
toxic chemicals.
There is general agreement that the chemi-
cals of greatest concern are toxics that persist in
the environment and bioconcentrate in living
organisms. Chemicals that have all three of
these properties are known as PBTs. They in-
clude DDT, PCBs, and dioxin. PBTs are responsi-
ble for some of the worst environmental con-
tamination in communities like Times Beach
and Love Canal. 
Using the PBT Profiler
The PBT Profiler evaluates a chemical’s struc-
ture for potential PBT properties. Users can access
the model at no charge at http://www.pbtpro-
filer.net. By entering a chemical’s CAS Registry
Number, they can obtain:
• information on the chemical’s potential PBT
characteristics; 
• a comparison of the Profiler’s predictions
against the EPA New Chemical Program cri-
teria for persistence, bioaccumulation, and
toxicity;
• information on environmental fate; and 
• information on “P2 considerations” to assist
in risk management of the chemical.
Input from Industry
Extensive effort was invested in development
of the PBT Profiler model. One factor contribut-
ing to its acceptance and wide use is that the
principal users (specifically, members of the
chemical industry) worked with EPA very early in
the development process.
The American Chemistry Council, the Syn-
thetic Organic Chemical Manufacturers Associ-
ation, and leading chemical manufacturers,
with assistance from Environmental Defense,
The chemicals of greatest concern
are toxics that persist in the
environment and bioconcentrate in
living organisms. 
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Qualifying for Regulatory Relief Under
Sustainable Futures
In order to qualify for regulatory relief in the
form of expedited PMN review, Sustainable Fu-
tures participants must demonstrate their compe-
tence in using the P2 Framework. In order to do
this, companies need to:
• take the necessary training;
• apply the P2 Framework and demonstrate to
EPA that this information helped guide deci-
sion-making regarding their PMN submis-
sion; and
• submit five to ten successful (i.e., not regu-
lated by EPA)
PMNs that they de-
veloped using the
P2 Framework.
OPPT will con-
tinue to independ-
ently evaluate each
Sustainable Futures
PMN submitted.
Working Collaboratively with Business 
Sustainable Futures is an effective forum for
the Agency and industry to work collaboratively
toward the shared goals of pollution prevention,
risk reduction, environmental stewardship, and
sustainability.
Companies can gain significant benefits from
prescreening new industrial chemicals using the
same models that EPA will use to review the same
chemical. Doing so allows users to identify po-
tential chemical toxicity, exposure issues, and ul-
timate risk problems even before the chemical is
synthesized.
By prescreening chemicals, companies can
identify problematic substances and search for
safer alternatives. If no substitute can be found
for a specific chemical, the company will have an
collaborated with EPA in developing the PBT
Profiler.
Sustainable Futures: EPA Scales Up the
Successful P2 Framework XL Projects 
The Agency was very pleased with the results
of the Kodak and PPG Project XL initiatives. As a
result, the Agency decided to “scale up” the con-
cepts and offer the program nationally so that
any company that prescreened new chemical
submissions could get regulatory relief.
On December 11, 2002, OPPT announced
the Sustainable Futures Pilot Project in a Federal
Register notice, which is available at http://
www.epa.gov/fedrgstr/EPA-TOX/2002/December/
Day-11/t31243.pdf. “Sustainable Futures” is the
name that has been given to the programmatic
structure developed by OPPT to make the benefits
of using the P2 Framework risk-screening meth-
ods available nationwide.
Benefits of Sustainable Futures
Under Sustainable Futures, OPPT is offering
the same form of regulatory relief to qualifying
participants that was offered to Kodak and PPG
under their Project XL agreements—that is, sub-
mission of the chemical substance as both a PMN
and a TME. By submitting a low-toxicity/low-risk
chemical under Sustainable Futures, the com-
pany can potentially go to manufacture at 45
days instead of 90, thus cutting the review time
in half.
The Sustainable Futures Pilot Project offers
participating companies:
• access to the P2 Framework and PBT Profiler
models;
• hands-on training with Agency experts;
• one-on-one detailed technical assistance;
• regulatory relief for qualifying new chemicals
(as described above); and
• a small business assistance program.
By prescreening chemicals,
companies can identify problematic
substances and search for safer
alternatives. 
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“early warning” about the risk concerns that need
to be mitigated. Including mitigation informa-
tion in the PMN submission can greatly speed
time to market. 
Lessons Learned from Working with Industry
Business Benefits of Prescreening Chemicals 
In the process of working cooperatively with
industry and helping them use the Agency’s
screening models, OPPT has learned that the great-
est potential benefits to companies may not come
from expedited review. Instead, participating com-
panies state that they perceive the greatest benefits
to be factors such as
greater business cer-
tainty, reduced product
development costs, de-
creased waste genera-
tion, increased innova-
tion, and enhanced
profits.
All of these factors
combine to give participating companies a com-
petitive advantage over those that do not pre-
screen chemicals at the research and develop-
ment stage. OPPT became aware of several of
these potential benefits while working with
Kodak and PPG on their Project XL initiatives.
Some key business benefits are highlighted briefly
below. 
• Business Certainty
Kodak found that prescreening chemicals at
the R&D stage provided greater business cer-
tainty, as documented by the Tellus Institute in
its previously described case study.
Using the P2 Framework to prescreen PMNs
allowed Kodak to predict the concerns the
Agency might have when the PMN was finally
submitted for review. This decreased regulatory
uncertainty and allowed Kodak to more confi-
dently estimate when production of the chemical
could begin. Kodak could now tell a client more
precisely when they could deliver the new chem-
ical. This represented a significant business ad-
vantage over their competitors.
• Reduction in Product Development Costs
This benefit was also documented by the Tel-
lus Institute report on Kodak’s experience. Being
able to determine whether a particular chemical
might create concerns greatly reduced the costs
required to identify successful candidate chemi-
cals and processes and bring new chemical prod-
ucts to market.
• Increased Innovation
Using chemical risk prescreening models fa-
cilitates increased innovation because it allows
the submitting company to consider many more
chemical alternatives. This increases their
chances of identifying a chemical with better per-
formance characteristics, or one that is more en-
vironmentally preferable, in addition to decreas-
ing the probability of regulation.
• Increased Profit
The factors described above can all contribute
to increased profits for companies that use chem-
ical risk prescreening models. In addition, these
companies’ profits can be enhanced further
through the intangible (but invaluable) positive
public relations benefits they realize by pre-
screening chemical alternatives at the research
and development stage. 
• Competitive Advantage
Overall competitive advantage is the major
benefit that is being realized by forward-thinking
companies that are incorporating product stew-
ardship methods (including prescreening of
chemicals using the P2 Framework methods) into
their operations.
Kodak found that prescreening
chemicals at the R&D stage pro-
vided greater business certainty.
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This is especially true of the PBT Profiler.
Major chemical companies, including SC John-
son and Bayer, are using the PBT Profiler to
screen many chemicals in order to pinpoint
those that may have concerns, or to identify the
most environmentally preferable chemical al-
ternative.
Like all screening models, the P2 Framework
and PBT Profiler have conservative defaults. They
are best used to prioritize chemicals and identify
potentially problematic chemicals for more de-
tailed evaluation.
Conclusion: A Win-Win-Win Outcome for
Industry, EPA, and the Environment 
The Sustainable Futures Pilot Project has been
a rewarding outreach effort. It has successfully
demonstrated that cooperative efforts can result
in the greatest benefits for everyone involved.
This is truly a “win-win-win” situation.
The chemical industry wins by increasing
profits and gaining competitive advantage.
EPA wins by advancing its pollution preven-
tion and risk reduction goals.
Most importantly, the environment wins be-
cause safer chemicals and processes are entering
commerce. 
For More Information
Additional information on Sustainable Fu-
tures is available at http://www.epa.gov/opptintr/
newchems/sustainablefutures.htm.
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Some Technologies Were Not as Transferable
as Hoped
The Agency is learning many additional valu-
able lessons during the outreach efforts to indus-
try that have culminated in the Sustainable Fu-
tures Pilot Project. One major lesson is that these
methods have sometimes not been as transferable
as OPPT had hoped.
An example is the critical step of selecting a
close analogue for a chemical that lacks data. Ac-
curately selecting a close analogue requires many
years of experience in chemistry and toxicology.
OPPT has highly skilled and experienced scien-
tists who have focused their careers on reviewing
toxicity studies and data, and gaining a sufficient
knowledge of toxic modes to be able to predict
how a chemical structure will control the ulti-
mate toxicity of that chemical.
Toxicologists with chemical companies often
have many functions, and cannot focus on be-
coming expert in selecting analogues. OPPT is ex-
ploring methods of capturing the hard-earned,
valuable expertise of its toxicologists and making
this available to industry.
Models Are Applicable to Both New and
Existing Chemicals 
The chemical risk-screening models that
OPPT developed to screen new chemicals sub-
mitted under TSCA are also being applied to ex-
isting chemicals. As discussed previously, most
existing chemicals in commerce lack the pub-
licly available data needed to adequately assess
their risk.
Now the OPPT screening models that have be-
come the focus of Sustainable Futures are being
used to screen groups of existing chemicals as
well. This allows the model users to identify ex-
isting chemicals that may pose concerns. It also
allows users to prioritize those chemicals that
should be evaluated first, or in greatest detail.
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